Patents Assigned to SYMBIOX, INC.
-
Patent number: 12616718Abstract: Systems and methods for developing and applying photosynthetic cellular substances to a human or animal for medical, therapeutic or cosmetic uses are provided. Photosynthetic cells, such as algal cells, can be used in these substances to provide the ability to continuously generate oxygen when exposed to a light source or other oxygen-generating trigger. The substances can be developed as a standalone liquid, gel or cream, or embedded within a bandage, mesh, scaffold or other structure with a light source to promote oxygen production. The substances can be applied topically for medical, therapeutic or cosmetic treatments, or injected internally for generation of oxygen within one or more parts of the body.Type: GrantFiled: April 24, 2023Date of Patent: May 5, 2026Assignee: SYMBIOX, INC.Inventor: Jose-Tomas Egana-Erazo
-
Patent number: 12600938Abstract: Methods of storage and preservation of photosynthetically active cells and photosynthetic biomaterials are provided herein. Contemplated methods comprise storing the cells and biomaterials at a refrigeration temperature, optionally without light. The stored cells and biomaterials may be placed in a nitrogen containing medium under illumination before use. The chlorophyll content, oxygen consumption rate, oxygen production rate and/or morphology may be substantially preserved throughout the storage and awakening process.Type: GrantFiled: October 28, 2021Date of Patent: April 14, 2026Assignee: SYMBIOX, INC.Inventors: Jose-Tomás Egaña-Erazo, Rocio Corrales-Orovio
-
Patent number: 12594299Abstract: Systems and methods for developing and applying photosynthetic cellular substances to a human or animal for medical, therapeutic or cosmetic uses are provided. Photosynthetic cells, such as algal cells, can be used in these substances to provide the ability to continuously generate oxygen when exposed to a light source or other oxygen-generating trigger. The substances can be developed as a standalone liquid, gel or cream, or embedded within a bandage, mesh, scaffold or other structure with a light source to promote oxygen production. The substances can be applied topically for medical, therapeutic or cosmetic treatments, or injected internally for generation of oxygen within one or more parts of the body.Type: GrantFiled: August 19, 2022Date of Patent: April 7, 2026Assignee: SYMBIOX, INC.Inventor: Jose-Tomas Egana-Erazo
-
Patent number: 12564604Abstract: Systems and methods for developing and applying photosynthetic cellular substances to a human or animal for medical, therapeutic or cosmetic uses are provided. Photosynthetic cells, such as algal cells, can be used in these substances to provide the ability to continuously generate oxygen when exposed to a light source or other oxygen-generating trigger. The substances can be developed as a standalone liquid, gel or cream, or embedded within a bandage, mesh, scaffold or other structure with a light source to promote oxygen production. The substances can be applied topically for medical, therapeutic or cosmetic treatments, or injected internally for generation of oxygen within one or more parts of the body.Type: GrantFiled: August 19, 2022Date of Patent: March 3, 2026Assignee: SYMBIOX, INC.Inventor: Jose-Tomas Egana-Erazo
-
Patent number: 12419907Abstract: Systems and methods for developing and applying photosynthetic cellular substances to a human or animal for medical, therapeutic or cosmetic uses are provided. Photosynthetic cells, such as algal cells, can be used in these substances to provide the ability to continuously generate oxygen when exposed to a light source or other oxygen-generating trigger. The substances can be developed as a standalone liquid, gel or cream, or embedded within a bandage, mesh, scaffold or other structure with a light source to promote oxygen production. The substances can be applied topically for medical, therapeutic or cosmetic treatments, or injected internally for generation of oxygen within one or more parts of the body.Type: GrantFiled: May 19, 2023Date of Patent: September 23, 2025Assignee: SYMBIOX, INC.Inventor: Jose-Tomas Egana-Erazo
-
Patent number: 12390501Abstract: The present invention is concerned with a photosynthetic scaffold that delivers oxygen and its uses for tissue engineering and the treatment of ischemia.Type: GrantFiled: April 25, 2023Date of Patent: August 19, 2025Assignee: SYMBIOX, INC.Inventors: Jose-Tomas Egana-Erazo, Hans-Gunther Machens, Ursula Hopfner, Joerg Nickelsen
-
Patent number: 11666616Abstract: The present invention is concerned with a photosynthetic scaffold that delivers oxygen and its uses for tissue engineering and the treatment of ischemia.Type: GrantFiled: September 15, 2020Date of Patent: June 6, 2023Assignee: SYMBIOX, INC.Inventors: Jose-Tomas Egana-Erazo, Hans-Gunther Machens, Ursula Hopfner, Joerg Nickelsen
-
Patent number: 11207362Abstract: The present invention is concerned with a photosynthetic scaffold that delivers oxygen and its uses for tissue engineering and the treatment of ischemia.Type: GrantFiled: December 18, 2017Date of Patent: December 28, 2021Assignee: SYMBIOX, INC.Inventors: Jose-Tomas Egana-Erazo, Hans-Gunther Machens, Ursula Hopfner, Joerg Nickelsen
-
Patent number: 9849150Abstract: The present invention is concerned with a photosynthetic scaffold that delivers oxygen and its uses for tissue engineering and the treatment of ischemia.Type: GrantFiled: September 29, 2015Date of Patent: December 26, 2017Assignee: SYMBIOX, INC.Inventors: Jose-Tomas Egana-Erazo, Hans-Gunther Machens, Ursula Hopfner, Joerg Nickelsen
-
Patent number: 9144589Abstract: The present invention is concerned with a photosynthetic scaffold that delivers oxygen and its uses for tissue engineering and the treatment of ischemia.Type: GrantFiled: March 22, 2011Date of Patent: September 29, 2015Assignee: SYMBIOX, INC.Inventors: Jose-Tomas Eagana-Erazo, Hans-Gunther Machens, Ursula Hopfner, Joerg Nickelsen